Hospira Inc. said Tuesday the Food and Drug Administration has approved its generic version of AstraZeneca’s antibiotic Merrem.
The FDA cleared Hospira’s version of intravenous meropenem in 500-milligram and 1-gram vials. Hospira said U.S. sales of Merrem totaled $200 million in 2009.